Advanced Search

Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2015 September;67(3) > Minerva Urologica e Nefrologica 2015 September;67(3):201-10

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536

Frequency: Bi-Monthly

ISSN 0393-2249

Online ISSN 1827-1758

 

Minerva Urologica e Nefrologica 2015 September;67(3):201-10

HOT TOPICS IN PROSTATE CANCER 

    REVIEWS

Magnetic resonance imaging for prostate cancer: what the urologist needs to know

Kiechle J. E. 1, Pahwa S. 2, Gulani V. 2, Kanaan G. 1, Sedelaar J. P. 3, Ponsky L. E. 1

1 Urology Institute, Case Western Reserve University, School of Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA;
2 Department of Radiology, Case Western Reserve University, School of Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA;
3 Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands

The use of magnetic resonance imaging (MRI) for prostate cancer imaging has been an area of burgeoning research activity with a goal of finding imaging characteristics that will allow for improved diagnosis and surveillance of prostate cancer. This article will review the MRI sequences currently used for imaging the prostate and describe the scoring and reporting system used by radiologists for prostate MRI known as the Prostate Imaging Reporting and Data System (PI-RADS). Current research regarding the role of prostate MRI for patients without prior biopsy, with prior negative biopsy and elevated PSA, and on active surveillance protocols will also be reviewed.

language: English


FULL TEXT  REPRINTS

top of page